O TYM ODCINKU
Autoimmune diseases like lupus and Type 1 diabetes are notoriously difficult to treat, but what if we could reprogram the immune system instead of turning it off entirely?
Preeminent immunologist Dr. Thomas Malek dives into the science behind a lab-designed fusion protein that could offer a powerful new path to long-term remission.
Język angielski
Stany Zjednoczone
TRANSKRYPCJA 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki Inside U Miami Medicine.
INNE ODCINKI W TYM PODCASCIE
AI isn’t replacing doctors: It’s making them better. Find out why Microsoft's Dr. James Weinstein believes AI can empower both patients and physicians, while shaping a new era of smarter, more efficient care.
Firefighters sprint into dangerous situations to protect their communities. But what happens when the very act of helping others puts their own lives at risk?
Dr. Erin Kobetz and Dr. Alberto Caban-Martinez - leaders of the Firefighter Cancer Initiative at Sylvester Comprehensive Cancer Center - pul…
Neurologist Dr. Ihtsham ul Haq reveals how cutting-edge technology is reshaping diagnosis and why stem cell therapies may hold the power to slow, or even reverse, the disease. Discover the breakthroughs, the setbacks and the race to change the future of Parkinson’s.
For the first time in history, there will soon be more older adults than children in the U.S., and rates of dementia are climbing.
Neuropsychologist Dr. Rosie Curiel Cid has developed a groundbreaking cognitive test capable of detecting the earliest signs of Alzheimer’s disease, long before sympto…
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z University of Miami Miller School of Medicine, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
